ResMed Inc. (RMD AU), the world's third-biggest maker of sleep disorder treatments, slumped 44 cents, or 7.1 percent, to A$5.76. RedMed reported earnings-per-share of 30 cents for the three months ended June 30, missing the average estimate for 36 cents by eight analysts surveyed by Thomson Financial.
why the drop, page-2
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$35.89 |
Change
-0.770(2.10%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $35.95 | $35.99 | $35.49 | $16.10M | 451.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 60 | $35.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $35.90 | 869 | 3 |
View Market Depth
| Last trade - 11.40am 15/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
